News
16h
MONTCO Today on MSNQVC Group to Proceed with Voluntary NASDAQ Stock DelistingDespite plans to implement a reverse stock split to boost the company’s share price, West Chester-based QVC Group is ...
Late-stage clinical biotechnology company developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease.
Investment in property funds; development investment and Property funds management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results